TB Research at UT-Houston - A review of cord factor: new approaches to drugs, vaccines and the pathogenesis of tuberculosis

Tuberculosis

Volumn 89, Issue SUPPL.1, 2009, Pages

  Hunter, Robert L ^a   Armitige, Lisa ^a   Jagannath, Chinnaswamy ^a   Actor, Jeffrey K ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Caseating granuloma; Cavity; Cord factor; dimycolate; Drug; Trehalose; Tuberculosis

Indexed keywords

ANTIBIOTIC AGENT; BCG VACCINE; CORD FACTOR; TUBERCULOSTATIC AGENT;

ARTICLE; DRUG ACTIVITY; DRUG CONFORMATION; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TUBERCULOSIS; UNITED STATES; UNIVERSITY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CORD FACTORS; DISEASE MODELS, ANIMAL; HUMANS; MACROPHAGES; MICE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUBERCULOSIS VACCINES;

EID: 72049083976     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-9792(09)70007-1     Document Type: Article

References (64)

1. Middlebrook G., Dubos R.G., and Pierce C. Virulence and morphological characteristics of mammalian tubercle bacilli. J Exp Med 86 (1947) 175-184
2. Bloch H. Studies on the virulence of tubercle bacilli: Isolation and biological properties of a constituent of virulent organisms. J Exp Med 91 (1950) 197-219
3. Bloch H. Virulence of mycobacteria. Adv Tuberc Res 6 (1955) 49-61
4. Bloch H., and Noll H. Studies on the virulence of tubercle bacilli. The effect of cord factor on murine tuberculosis. British J Exp Path 36 (1955) 8-17
5. Dubos R., and Dubos G. The White Plague. Tuberculosis, man, and society (1987), Rutgers University Press, Brunswick, NJ
6. Spitznagel J.K., and Dubos R.J. A fraction of tubercle bacilli possessing primary toxicity. J Exp Med 101 (1955) 291-311
7. Youmans G.P. Chapter 3. Biologic activities of mycobacterial cells and cell components. In: Youmans G.P. (Ed). Tuberculosis (1979), W.B. Saunders, Philadelphia, PA 46-62
8. Kuhn T.S. The structure of scientific revolutions (1966), University of Chicago Press, Chicago, IL
9. Hunter R., Strickland F., and Kezdy F. The adjuvant activity of nonionic block polymer surfactants I. The role of hydrophile-lipophile balance. J Immunol 127 (1981) 1244-1250
10. Newman M.J., Actor J.K., Balusubramanian M., and Jagannath C. Use of nonionic block copolymers in vaccines and therapeutics. Crit Rev Ther Drug Carrier Syst 15 (1998) 89-142
11. Retzinger G.S., Meredith S.C., Takayama K., Hunter R.L., and Kezdy F.J. The role of surface in the biological activities of trehalose 6,6-dimycolate. Surface properties and development of a model system. J Biol Chem 256 (1981) 8208-8216
12. Behling C.A., Bennett B., Takayama K., and Hunter R.L. Development of a trehalose 6,6-dimycolate model which explains cord formation by Mycobacterium tuberculosis. Infect Immun 61 (1993) 2296-2303
13. Schabbing R.W., Garcia A., and Hunter R.L. Characterization of the trehalose 6,6-dimycolate surface monolayer by scanning tunneling microscopy. Infect Immun 62 (1994) 754-756
14. Retzinger G.S., Meredith S.C., Hunter R.L., Takayama K., and Kezdy F.J. Identification of the physiologically active state of the mycobacterial glycolipid trehalose 6,6-dimycolate and the role of fibrinogen in the biologic activities of trehalose 6,6-dimycolate monolayers. J Immunol 129 (1982) 735-744
15. Wiessner J.H., Henderson J.J., Sohnle P.G., Mandel N.S., and Mandel G.S. The effect of crystal structure on mouse lung inflammation and fibrosis. Am Rev Respir Dis 138 (1988) 445-450
16. Syed S.S., and Hunter R.L. The toxicity of TDM for macrophages depends on its surface structure. FASEB J 9 (1995) A509
17. Lam C.W., James J.T., McCluskey R., and Hunter R.L. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 77 (2004) 126-134
18. Hunter R.L., Olsen M.R., Jagannath C., and Actor J.K. Multiple roles of cord factor in the pathogenesis of primary, secondary, and cavitary tuberculosis, including a revised description of the pathology of secondary disease. Ann Clin Lab Sci 36 (2006) 371-386
19. Hunter R.L., Olsen M., Jagannath C., and Actor J.K. Trehalose 6,6-dimycolate and lipid in the pathogenesis of caseating granulomas of tuberculosis in mice. Am J Pathol 168 (2006) 1249-1261
20. Hunter R.L., Jagannath C., and Actor J.K. Pathology of postprimary tuberculosis in humans and mice: contradiction of long-held beliefs. Tuberculosis (Edinb) 87 (2007) 267-278
21. Jagannath C., Emanuele M.R., and Hunter R.L. Activity of poloxamer CRL-1072 against drug-sensitive and resistant strains of Mycobacterium tuberculosis in macrophages and in mice. Int J Antimicrob Agents 15 (2000) 55-63
22. Jagannath C., Lindsey D.R., Dhandayuthapani S., Xu Y., Hunter Jr. R.L., and Eissa N.T. Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nat Med 15 (2009) 267-276
23. Hunter R.L., Venkataprasad N., and Olsen M.R. The role of trehalose dimycolate (cord factor) on morphology of virulent M. tuberculosis in vitro. Tuberculosis 86 5 (2006 Sep) 349-356
24. Arora A, Armitige LY, Wanger A, Hunter R. Production of trehalose dimycolate (TDM) by pulmonary and extrapulmonary isolates of Mycobacterium. ASM Abstracts 108th General Meetimg 2008; U-053/0933.
25. Jarlier V., and Nikaido H. Mycobacterial cell wall: structure and role in natural resistance to antibiotics [Review]. FEMS Microbiol Lett 123 (1994) 11-18
26. Hart D.P. Mycobacterium tuberculosis in macrophages: Effect of certain surfactants and other membrane active compounds. Science 162 (1968) 686-689
27. Anonymous. WHO Report 2006. Global tuberculosis control - surveillance, planning, financing. WHO/HTM/TB/2006362 (2006), World Health Organization, Geneva, Switzerland
28. Pagel W., Simmonds F., MacDonald N., and Nassau E. Chapter 3. The morbid anatomy and histology of tuberculosis, an introduction in simple terms. Pulmonary tuberculosis, bacteriology, pathology, management, epidemiology and prevention (1964), Oxford University Press, London 36-63
29. Rich A. The Pathogenesis of tuberculosis. second edition (1951), Charles C Thomas, Springfield, Illinois
30. Ojha A.K., Baughn A.D., Sambandan D., Hsu T., Trivelli X., Guerardel Y., et al. Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria. Mol Microbiol 69 (2008) 164-174
31. Bloch H., and Noll H. Studies on the virulence of tubercle bacilli. Variations in the virulence effect elicited by Tween 80 and thiosemicarbazone. Br J Exp Pathol 97 (1953) 1-16
32. Silva C.L. Participation of tumor necrosis factor in the antitumor activity of mycobacterial trehalose dimycolate (cord factor). Braz J Med Biol Res 22 (1989) 341-344
33. Indrigo J., Hunter Jr. R.L., and Actor J.K. Cord factor trehalose 6,6-dimycolate (TDM) mediates trafficking events during mycobacterial infection of murine macrophages. Microbiology 149 (2003) 2049-2059
34. Indrigo J., Hunter Jr. R.L., and Actor J.K. Influence of trehalose 6,6-dimycolate (TDM) during mycobacterial infection of bone marrow macrophages. Microbiology 148 (2002) 1991-1998
35. Kan-Sutton C., Jagannath C., and Hunter Jr. R.L. Trehalose 6,6-dimycolate on the surface of Mycobacterium tuberculosis modulates surface marker expression for antigen presentation and costimulation in murine macrophages. Microbes Infect 11 (2009) 40-48
36. Armitige L.Y., Jagannath C., Wanger A.R., and Norris S.J. Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages. Infect Immun 68 (2000) 767-778
37. Copenhaver R.H., Sepulveda E., Armitige L.Y., Actor J.K., Wanger A., Norris S.J., et al. A mutant of Mycobacterium tuberculosis H37Rv that lacks expression of antigen 85A is attenuated in mice but retains vaccinogenic potential. Infect Immun 72 (2004) 7084-7095
38. Hwang S.A., Wilk K., Kruzel M.L., and Actor J.K. A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice. Vaccine 27 (2009) 3026-3034
39. Trump B.F., Berezesky I.K., Chang S.H., and Phelps P.C. The pathways of cell death: oncosis, apoptosis, and necrosis. Toxicol Pathol 25 (1997) 82-88
40. Geisel R.E., Sakamoto K., Russell D.G., and Rhoades E.R. In vivo activity of released cell wall lipids of Mycobacterium bovis Bacillus Calmette-Guerin is due principally to trehalose mycolates. J Immunol 174 (2005) 5007-5015
41. Hunter R.L., and Bennett B. Mycobacterial cord factor kills macrophages by a membrane adhesive mechanism. Am Soc Microbiol Abstracts (1987) 129 ISSN 0067-2777.
42. Bekierkunst A., Levij I.S., Yarkoni E., Vilkas E., Adam A., and Lederer E. Granuloma formation induced in mice by chemically defined mycobacterial fractions. J Bacteriol 100 (1969) 95-102
43. Bekierkunst A., and Yarkoni E. Granulomatous hypersensitivity to trehalose 6,6-dimycolate (cord factor) in mice infected with BCG. Infect Immun 7 (1973) 631-638
44. Actor J.K., Olsen M., Hunter Jr. R.L., and Geng Y.J. Dysregulated response to mycobacterial cord factor trehalose-6,6-dimycolate in CD1D-/-mice. J Interferon Cytokine Res 21 (2001) 1089-1096
45. Perez R.L., Roman J., Roser S., Little C., Olsen M., Indrigo J., et al. Cytokine message and protein expression during lung granuloma formation and resolution induced by the mycobacterial cord factor trehalose-6,6-dimycolate. J Interferon Cytokine Res 20 (2000) 795-804
46. Welsh K.J., Abbott A.N., Hwang S.A., Indrigo J., Armitige L.Y., Blackburn M.R., et al. A role for tumour necrosis factor-alpha, complement C5 and interleukin-6 in the initiation and development of the mycobacterial cord factor trehalose 6,6-dimycolate induced granulomatous response. Microbiology 154 (2008) 1813-1824
47. Jagannath C., Hoffmann H., Sepulveda E., Actor J.K., Wetsel R.A., and Hunter R.L. Hypersusceptibility of A/J mice to tuberculosis is in part due to a deficiency of the fifth complement component (C5). Scand J Immunol 52 (2000) 369-379
48. Actor J.K., Breij E., Wetsel R.A., Hoffmann H., Hunter Jr. R.L., and Jagannath C. A role for complement C5 in organism containment and granulomatous response during murine tuberculosis. Scand J Immunol 53 (2001) 464-474
49. Borders C.W., Courtney A., Ronen K., Pilar Laborde-Lahoz M., Guidry T.V., Hwang S.A., et al. Requisite role for complement C5 and the C5a receptor in granulomatous response to mycobacterial glycolipid trehalose 6,6-dimycolate. Scand J Immunol 62 (2005) 123-130
50. Abbott A.N., Guidry T.V., Welsh K.J., Thomas A.M., Kling M.A., Hunter R.L., et al. 11beta-hydroxysteroid dehydrogenases are regulated during the pulmonary granulomatous response to the mycobacterial glycolipid trehalose-6,6-dimycolate. Neuroimmunomodulation 16 (2009) 147-154
51. Guidry T.V., Hunter Jr. R.L., and Actor J.K. CD3+ cells transfer the hypersensitive granulomatous response to mycobacterial glycolipid trehalose 6,6-dimycolate in mice. Microbiology 152 (2006) 3765-3775
52. Guidry T.V., Hunter Jr. R.L., and Actor J.K. Mycobacterial glycolipid trehalose 6,6-dimycolate-induced hypersensitive granulomas: contribution of CD4+ lymphocytes. Microbiology 153 (2007) 3360-3369
53. Guidry T.V., Olsen M., Kil K.S., Hunter Jr. R.L., Geng Y.J., and Actor J.K. Failure of CD1D-/-mice to elicit hypersensitive granulomas to mycobacterial cord factor trehalose 6,6-dimycolate. J Interferon Cytokine Res 24 (2004) 362-371
54. Pagel W., and Pagel M. Zur Histochemie der Lungentuberkulose, mit besonderer Ber ücksichtigung der Fettsubstanzen und Lipoide [Fat and lipoid content to tuberculous tissue. Histochemical investigation]. Virchows Arch path Anat 256 (1925) 629-640
55. Osler W. Chapter 26, Tuberculosis. The principles and practice of medicine (1892), D. Appleton and Company, New York 184-255
56. Mays T.J. Pathology of pulmonary consumption. Pulmonary consumption, pneumonia and allied diseaeses of the lungs: their etiology, pathology and treatment - with a chapter on physical diagnosis (1901), E.B. Treat & Company, New York 247-288
57. Dannenberg Jr. A.M. Pathogenisis of human pulmonary tuberculosis. Insights from the rabbit model (2006), ASM press, Washington, DC
58. Creighton C. Bovine tuberculosis in man: an account of the pathology of suspected cases (1881), MacMillan and Co., London
59. Kashyap S., Mohapatra P.R., and Saini V. Endobronchial tuberculosis. Indian J Chest Dis Allied Sci 45 (2003) 247-256
60. Tamura A., Hebisawa A., Fukushima K., Yotsumoto H., and Mori M. Lipoid pneumonia in lung cancer: radiographic and pathological features. Jpn J Clin Oncol 28 (1998) 492-496
61. Peyron P., Vaubourgeix J., Poquet Y., Levillain F., Botanch C., Bardou F., et al. Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog 4 (2008) e1000204.
62. North R.J., and Jung Y.J. Immunity to tuberculosis. Annu Rev Immunol 22 (2004) 599-623
63. Mustafa T., Phyu S., Nilsen R., Jonsson R., and Bjune G. In situ expression of cytokines and cellular phenotypes in the lungs of mice with slowly progressive primary tuberculosis. Scand J Immunol 51 (2000) 548-556
64. Laennec R. A treatise on diseases of the chest in which they are described according to their anatomical characters, and their diagnosis established on a new principle by means of acoustick instruments (1821), T&G Underwood, London [Reprinted 1979 by The Classics of Medicine Library. Birmingham, AL.]